These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30528960)

  • 21. Hyperactivity of caudate, parahippocampal, and prefrontal regions during working memory in never-medicated persons at clinical high-risk for psychosis.
    Thermenos HW; Juelich RJ; DiChiara SR; Mesholam-Gately RI; Woodberry KA; Wojcik J; Makris N; Keshavan MS; Whitfield-Gabrieli S; Woo TU; Petryshen TL; Goldstein JM; Shenton ME; McCarley RW; Seidman LJ
    Schizophr Res; 2016 May; 173(1-2):1-12. PubMed ID: 26965745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurocognitive growth charting in psychosis spectrum youths.
    Gur RC; Calkins ME; Satterthwaite TD; Ruparel K; Bilker WB; Moore TM; Savitt AP; Hakonarson H; Gur RE
    JAMA Psychiatry; 2014 Apr; 71(4):366-74. PubMed ID: 24499990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurocognitive Functioning in Individuals at Clinical High Risk for Psychosis: A Systematic Review and Meta-analysis.
    Catalan A; Salazar de Pablo G; Aymerich C; Damiani S; Sordi V; Radua J; Oliver D; McGuire P; Giuliano AJ; Stone WS; Fusar-Poli P
    JAMA Psychiatry; 2021 Jun; 78(8):859-67. PubMed ID: 34132736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain grey matter abnormalities in first episode non-affective psychosis patients with suicidal behaviours: The role of neurocognitive functioning.
    Canal-Rivero M; Tordesillas-Gutiérrez D; Ruiz-Veguilla M; Ortiz-García de la Foz V; Cuevas-Esteban J; Marco de Lucas E; Vázquez-Bourgon J; Ayesa-Arriola R; Crespo-Facorro B
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Aug; 102():109948. PubMed ID: 32305356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal Changes in Cortical Surface Area Associated With Transition to Psychosis in Adolescents at Clinical High Risk for the Disease.
    Fortea A; van Eijndhoven P; Ilzarbe D; Batalla A; Calvet-Mirabent A; de la Serna E; Puig O; Castro-Fornieles J; Dolz M; Tor J; Parrilla S; Via E; Stephan-Otto C; Baeza I; Sugranyes G
    J Am Acad Child Adolesc Psychiatry; 2023 May; 62(5):593-600. PubMed ID: 36638884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinguishing prodromal from first-episode psychosis using neuroanatomical single-subject pattern recognition.
    Borgwardt S; Koutsouleris N; Aston J; Studerus E; Smieskova R; Riecher-Rössler A; Meisenzahl EM
    Schizophr Bull; 2013 Sep; 39(5):1105-14. PubMed ID: 22969150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal change in neurocognition and its relation to symptomatic and functional changes over 2years in individuals at clinical high-risk for psychosis.
    Shin YS; Kim SY; Lee TY; Hur JW; Shin NY; Kim SN; Shin MS; Kwon JS
    Schizophr Res; 2016 Jul; 174(1-3):50-57. PubMed ID: 27068568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of neuroanatomical pattern regression to predict the structural brain dynamics of vulnerability and transition to psychosis.
    Koutsouleris N; Gaser C; Bottlender R; Davatzikos C; Decker P; Jäger M; Schmitt G; Reiser M; Möller HJ; Meisenzahl EM
    Schizophr Res; 2010 Nov; 123(2-3):175-87. PubMed ID: 20850276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multivariate patterns of brain-cognition associations relating to vulnerability and clinical outcome in the at-risk mental states for psychosis.
    Koutsouleris N; Gaser C; Patschurek-Kliche K; Scheuerecker J; Bottlender R; Decker P; Schmitt G; Reiser M; Möller HJ; Meisenzahl EM
    Hum Brain Mapp; 2012 Sep; 33(9):2104-24. PubMed ID: 22887825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meta-analysis of longitudinal neurocognitive performance in people at clinical high-risk for psychosis.
    Hedges EP; See C; Si S; McGuire P; Dickson H; Kempton MJ
    Psychol Med; 2022 Aug; 52(11):2009-2016. PubMed ID: 35821623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurocognitive function as a possible marker for remission from clinical high risk for psychosis.
    Lee TY; Shin YS; Shin NY; Kim SN; Jang JH; Kang DH; Kwon JS
    Schizophr Res; 2014 Mar; 153(1-3):48-53. PubMed ID: 24529365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disorganized Gyrification Network Properties During the Transition to Psychosis.
    Das T; Borgwardt S; Hauke DJ; Harrisberger F; Lang UE; Riecher-Rössler A; Palaniyappan L; Schmidt A
    JAMA Psychiatry; 2018 Jun; 75(6):613-622. PubMed ID: 29710118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroanatomical correlates of executive dysfunction in the at-risk mental state for psychosis.
    Koutsouleris N; Patschurek-Kliche K; Scheuerecker J; Decker P; Bottlender R; Schmitt G; Rujescu D; Giegling I; Gaser C; Reiser M; Möller HJ; Meisenzahl EM
    Schizophr Res; 2010 Nov; 123(2-3):160-74. PubMed ID: 20826078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropsychological Performance Among Individuals at Clinical High-Risk for Psychosis vs Putatively Low-Risk Peers With Other Psychopathology: A Systematic Review and Meta-Analysis.
    Millman ZB; Roemer C; Vargas T; Schiffman J; Mittal VA; Gold JM
    Schizophr Bull; 2022 Sep; 48(5):999-1010. PubMed ID: 35333372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurocognitive dysfunction in subjects at clinical high risk for psychosis: A meta-analysis.
    Zheng W; Zhang QE; Cai DB; Ng CH; Ungvari GS; Ning YP; Xiang YT
    J Psychiatr Res; 2018 Aug; 103():38-45. PubMed ID: 29772485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early recognition and disease prediction in the at-risk mental states for psychosis using neurocognitive pattern classification.
    Koutsouleris N; Davatzikos C; Bottlender R; Patschurek-Kliche K; Scheuerecker J; Decker P; Gaser C; Möller HJ; Meisenzahl EM
    Schizophr Bull; 2012 Nov; 38(6):1200-15. PubMed ID: 21576280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Various neurocognitive deficits and conversion risk in individuals at clinical high risk for psychosis.
    Mourik K; Decrescenzo P; Brucato G; Gill KE; Arndt L; Kimhy D; Keilp JG; Girgis RR
    Early Interv Psychiatry; 2017 Jun; 11(3):250-254. PubMed ID: 26663764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroanatomical correlates of different vulnerability states for psychosis and their clinical outcomes.
    Koutsouleris N; Schmitt GJ; Gaser C; Bottlender R; Scheuerecker J; McGuire P; Burgermeister B; Born C; Reiser M; Möller HJ; Meisenzahl EM
    Br J Psychiatry; 2009 Sep; 195(3):218-26. PubMed ID: 19721111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Learning to trust: social feedback normalizes trust behavior in first-episode psychosis and clinical high risk.
    Lemmers-Jansen ILJ; Fett AJ; Hanssen E; Veltman DJ; Krabbendam L
    Psychol Med; 2019 Apr; 49(5):780-790. PubMed ID: 29897026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transition.
    Koutsouleris N; Meisenzahl EM; Davatzikos C; Bottlender R; Frodl T; Scheuerecker J; Schmitt G; Zetzsche T; Decker P; Reiser M; Möller HJ; Gaser C
    Arch Gen Psychiatry; 2009 Jul; 66(7):700-12. PubMed ID: 19581561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.